Key TakeawaysShares of Grail, a medical technology company, jumped 20% Wednesday to lead Nasdaq 100 gainers.Grail spun off from Illumina last year, and is developing a number of early detection cancer screening products.Last week, Grail said it sees fiscal 2025 sales of its Galleri blood test up 20% to 30% year-over-year. Shares of Grail, Inc. (GRAL) surged 20% intraday Wednesday, putting the medical technology company above the likes of Arm Holdings (ARM) and Netflix (NFLX) to be the biggest gainer in the ...